The AI Healthcare Podcast (Dylan Reid)

In this episode, I sit down with my friend, AI Researcher and Advisor, Sergei Polevikov. 

To find more about Sergei find him on Linkedin, or go to any of these websites here: 

Substack: sergeiAI.substack.com
Twitter: @AIHealthUncut
WellAI website: https://wellai.health


Episode is available on Apple Podcasts, Spotify, and Youtube. 
Dylan Reid
Youtube:AIHealthcarePodcast
X:@AIHealthcarePod
Linkedin: The AI Healthcare Report

In this episode, I sit down with my friend, Physician and CEO of IMedHealth, Dr. Umer Khan

To find more about Umer find him on Linkedin, or go to the IMedHealth Website below:

Website: https://imedhealth.us/

Episode is available on Apple Podcasts, Spotify, and Youtube. 
Dylan Reid
Youtube:AIHealthcarePodcast
X:@AIHealthcarePod
Linkedin: The AI Healthcare Report

In this episode, I sit down with my friend and CEO of Calmwave, Ophir Ronen.

To find more about Ophir find him on Linkedin, or go to the Calmwave Website below:

Website: https://calmwave.ai/

Episode is available on Apple Podcasts, Spotify, and Youtube. 
Dylan Reid
Youtube:AIHealthcarePodcast
X:@AIHealthcarePod
Linkedin: The AI Healthcare Report

Our own Dylan Reid sits down for an interview with Tanner Aliff to explore health policy on both the federal and state level.  

P.S. The AI Healthcare Podcast is now part of the Forest Hill Labs Family! 

Key Takeaways

1.A continuous framework development that eases physician workflows and is patient-centric is needed to create empathy in constructing health solutions for patients.  

2.It is challenging to come up with governmental regulation fast enough for A.I. in healthcare because technology moves so quickly, which translates to private companies self-regulating themselves.  

3.We are entering a phase where A.I. Technology is evolving quicker than our education.  

Where are EU regulations headed when it comes to A.I. in healthcare? With his expertise in the Italian market in pharmaceutical marketing and sales, Manuel Mitola, MBA Mitola teaches us how A.I. is being adopted and used in Europe. He also educates us on key legislative priorities while also balancing innovation on the European continent.

Key takeaways:

1. Each Italian state has slightly different rules in the marketing of pharmaceuticals depending on the region.

2. GDPR does not explicitly mention A.I. because the regulation came into being before A.I. was broadly known and the law is vague on prescriptions.

3. Pharmaceutical companies in Europe are risk adverse in Europe and interpret GRPR in the most conservative manner, which means applying a limitation on the usage of data.

The A.I. Healthcare Podcast is now part of the Forest Hill Labs Family.

Sign up at www.foresthilllabs.net to get Forest Hill Labs: A Health Market Intelligence, Policy, and Thought Leadership Consultancy content!

What does the future of A.I. in healthcare look like in Australia? Where are the potential challenges and opportunities for implementing A.I. technology in the country? Come learn from Australia A.I. Healthcare expert and Founder of NurseFusion, Sarah Hughes, as we uncover these questions. We had to switch to Zoom because of some technical difficulties. 

Linkedin:   / sarahhughesleadingchange 

Nursefusion Website: https://nursefusion.com.au/

Cover/Episode Art made by Daniel Maley with Dall-E

Have you ever been curious about learning about navigating the U.S. Healthcare System from the perspective of an immigrant? In this interview, I sit down with my friend and COO of BeKey, Alex Koshykov on his story on navigating healthcare in the United States and its differences to his home country of Ukraine.

Connect with Alex here. 

Be sure to read his newsletter US Healthcare, which can be found on his Linkedin!

What is brain health? CEO + Co-Founder of DigiCARE Realized and Global Consortium Member of Social Impact Partners educates us on why brain health is crucial in pushing healthcare forward in the United States.

To connect with Brittany please find her Linkedin here. 

Key takeaways:

1.Being intentional for treatments and cures are needed to make the necessary advancements for brain health so that families or those impacted have access to the resources that they need. 

2. Having an understanding of the pathology of diseases, such as Alzheimer's can provide clinicians with more personalized, effective treatment plans.

3.Shifting from being reactive to proactive is essential to understanding brain health.

How do we expedite the drug approval process in the United States? Co-Founder & CEO of EVQLV, Andrew Satz, educates us on how and what is needed to do so. 

To find out more about Andrew, please find him on LinkedIn here: https://www.linkedin.com/in/andrewsatz/

To find out more about EVQLV, please find the company website here: https://evqlv.com/

Key takeaways:

1. The acceleration of getting drugs to patients by decreasing costs for researchers, industry, and other key stakeholders motivates EVQLV.

2. A.I. will cause hyper-specialization, which will make doctors become more productive. 

3. Making data more accessible through government agencies and investing at a governmental level will drive future A.I.  models and specialized medicines for populations.

How do we showcase cities, such as those of Baton Rouge, Louisiana maintain a key importance in the role of A.I. technology implementation in healthcare in the United States? Adjunct Instructor at Louisiana State University in Baton Rouge, Co-Founder of Disrupt Ready, Henry Hays, educates us on the progress, but also what is still needed to make cities in the South, such as Baton Rouge ready for the future.

To find out more about Henry, please find him on LinkedIn here:  https://www.linkedin.com/in/henryhays/ 

Key takeaways:
1. The A.I. economy in southern cities, such as Baton Rouge is still in its early stages. 

2. Southern businesses that understand what is and is not A.I. and then implement it will be the ones that survive in the future.

3. LSU is leading the way in A.I. education by constructing classes that allow students to learn, and build large language models that solve problems for businesses, which can lead to full-time employment for students.

What is Medical Affairs? Medical Affairs Expert Luisa Scott educates us on the field and why is it a crucial component of health care operations.

To learn more about Luisa, find her on Linkedin here:  https://www.linkedin.com/in/luisa-scott-phd/ 

Key takeaways:

1. Medical Affairs can be divided into two elements, which are the following:

i. Field Medical Team-tasked with providing non-promotional materials to healthcare providers and digging into the respective data.

ii. Post-market data collection- which patients are benefitting from the medical product?

2. One struggle that medical affairs professionals have faced among key health care stakeholders is how the utilization of medical products impacts the commercial strategies of companies. 

3. One of the values that Medical Affairs brings to the organization is the ability for the field to analyze, and crunch data to make it more accessible to consumers in real-time.

In this episode, I sit down with AI Entrepreneur and friend Peter Skuta on his invention the "AI Child" and how the "AI Child" can be used to increase health outcomes domestically and globally.

To find more about Peter, find him on Linkedin. 

Episode is available on Apple Podcasts, Spotify, and Youtube. 

In this episode, I sit down with Generative AI Consultant, Chapter President to the Kansas City Generative AI Committee for the VR/AR Association, and an advisory board member to the University of Kansas School of Nursing; my friend Doug Hohulin.

To find more about Doug, find him on Linkedin.

Episode is available on Apple Podcasts, Spotify, and Youtube. 

Dylan Reid
Youtube:AIHealthcarePodcast
X:@AIHealthcarePod
Linkedin: The AI Healthcare Report

In this episode, I sit down with my friend, CEO of Genialis, and Co-founder, Board Director & Executive Committee Member of the Alliance for Artificial Intelligence in Healthcare, Rafael Rosengarten.

To find more about Rafael, find him on Linkedin, genialis.com, or at theaaih.org.

Episode is available on Apple Podcasts, Spotify, and Youtube. 

Dylan Reid
Youtube:AIHealthcarePodcast
X:@AIHealthcarePod
Linkedin: The AI Healthcare Report

In this episode, I sit down with my friend, CEO of WUWTA, Jonathan Sachs.

To find more about Jonathan find him on Linkedin, or go to https://getwuwta.com/

Episode is available on Apple Podcasts, Spotify, and Youtube. 

Dylan Reid
Youtube:AIHealthcarePodcast
X:@AIHealthcarePod
Linkedin: The AI Healthcare Report

What is FemTech and how it will revolutionize female health as it relates to A.I. healthcare? Ioanna Deni of Intelligence Ventures provides an overview of how to define the FemTech industry and what regulations need to happen to make sure FemTech products are safe.

Find her on LinkedIn. 

Key takeaways:

1. Femtech is a term that describes technologies and innovations around women’s health. 

2. Women’s health is a largely unexplored market, which makes the demand for Femtech exponential. 

3. There are regulatory differences between the unlearned or “raw data” and learned data produced by the algorithm

What is needed for A.I. to be successfully implemented in healthcare environments? Sigrid Berge van Rooijen educates us on how it is possible.

To find out more about Sigrid, find her on LinkedIn here:  / sigridberge 

Key Takeaways:

1. The medical history of a patient is essential in providing them with the right treatments, but also understanding them as a person.

2. A.I. can help medical professionals decide what is the most important treatment for patients to when to schedule their next appointment. 

3. Education is needed for both patients and doctors to understand that A.I. is helpful and not a hindrance in healthcare operations.

To connect with Ashley, find her on LinkedIn here:  / ashley-a-gross 

Key Takeaways:

1. Accessibility and Affordability are two goals that she aims to help people build their respective dreams, while building life-long connections with others. 

2. Older generations are more eager to learn about A.I. technology than younger individuals because of the fear of missing out aka ("FOMO").

3. A.I. has mobilized people in both "centralized" and "de-centralized" manners.

How can the healthcare system change from a direct care to an educational model? Head of Legal Tracy Health, Sarah Covington, educates us on what is needed to happen.

To connect with Sarah, find her on LinkedIn here: 

Key takeaways:

1. More resources need to be given to caregivers to ease the burden on nurses, but there is still an educational gap in how to treat wounds inside the home.

2. Healthcare in America, specifically in rural areas of the country means having access to essential services, such as ambulances and pediatric cardiologists. 

3. Cost of deductibles in rural environments remains an issue for residents who need access to much-needed services.

How can we develop new data visualization algorithms to make clinical recommendations to help medical professionals and patients make better decisions about their health?

Come find out how Estenda Solutions uses AI in healthcare to solve this question.

To connect with RJ, find him here: / rjkedziora 

Key takeaways:

1. Understanding what occurs between patient appointments is crucial to solving health problems domestically and globally.

2. Diabetic retinopathy is the leading cause of preventable blindness in the Native American population, community health centers must have the resources they need to treat the ailment.

3. Congress must embrace AI in healthcare and understand its possibilities and provide guidance and support to help industry innovate. 

To connect with RJ and learn about Estenda Solutions, please see the following resources below:

Facebook: / estendasolutions 
Linkedin:  / rjkedziora 
Instagram: / estendasolutions 
X: / estenda 
Youtube: / @estendasolutionsinc  

How can we use A.I. to create customized solutions to empower people to take control of their health? Chairman and CEO of MediKarma, Inc., Kris Narayan educates us on how it can be done.

Connect with Kris here:  / krisnarayan 

Learn more about MediKarma here: https://www.medikarma.com/

Key Takeaways:

1. MediKarma is focused on the best practices for patient engagement in preventative care, even if it is incremental.

2. Patient responsibility is essential in improving health outcomes while decreasing costs for insurance companies. 

3. We need to be less profit-oriented and more health-oriented when fixing healthcare.

How do we showcase Southern States, such as Mississippi where the field of A.I. can proliferate? Jim St. Clair teaches us how (not to mention it was a must to discuss Hotty Toddy football).

To connect with Jim, please find him on LinkedIn here.

Learn about the Mississippi Coding Academies, please click here.

Key Takeaways:

1. Mississippi is currently in the beginning stages of integrating and collaborating on an A.I. curriculum between in-state higher education institutions and several SEC universities. 

2. The state government has been influential in ensuring that Mississippi has a workforce ready to support the next wave of innovation.

3. Healthcare organizations in Mississippi should look to the Mississippi Coding Academies as their first and best resource for trained developers and programmers to work on A.I. innovations in the state.

How is A.I. being used to help extract data from clinical notes to help improve outcomes for patients while assisting clinicians to do their jobs more effectively and efficiently? Co-founder and CEO of Pentavere AI, A Healwell AI company, Aaron Leibtag, educates us on how Pentavere is solving the problem.

To connect with Aaron, please connect with him here.

To learn more about Pentavere, please go to their website here.

To learn more about Healwell AI, please go to their website here, 

Key Takeaways:

1. There is a plethora of health data, but it is currently not being used effectively to improve patient outcomes. 

2. So much of our healthcare data is written in long form, which makes it challenging for clinicians to understand the needs of patients in a timely fashion. 

3. People did not think that computers or natural language understanding could make sense of clinical documentation until it was tested to be true.

What is "systematic selling" and how does it translate to being successful in sales, such as in the AI Healthcare space? Founder and CEO of Systematic Selling and Host of the Systematic Selling Podcast, Sean Lyden, educates us on how it is possible.

To connect with Sean, visit him on Linkedin here: https://www.linkedin.com/in/seanlyden/

Subscribe to the Systematic Newsletter here: https://www.systematicselling.co/

Listen to the Systematic Selling Podcast here: https://www.systematicselling.co/podcast

Buy a copy of Collaboration Effect on Profit: Overcoming Founder's Syndrome to Achieve Sustainable Success here: https://www.amazon.com/Collaboration-Effect-Profit-Overcoming-Sustainable/dp/B0CZ89TN8P/ref=sr_1_1?dib=eyJ2IjoiMSJ9.gE6SiUPWZSqQV2TMTUbEwIoJ_-NgkSiJFD_nL_IB7-A.EQlXs fjMz6njNv_JWdTiUt1YArudvefq2viyWXocwI&dib_tag=se&keywords=Sean+M.+Lyden&qid=1728151430&s=audible&sr=1-1-catcorr

Key Takeaways:

1. Systematic selling takes a systematic and intentional approach, ranging from a company's sales system to developing sales talent into a high-performing team. 

2. The right systems will allow organizations to reach their fullest potential. 

3. Sales and Relationship Building is ranked by a trust continuum from 0-10 (0 being untrustworthy and 10 being impeccable trust).

How do we prevent health professional burnout AND break down barriers for patients to communicate with providers globally while being patient-centric in the process? Founder & CEO of Upvio, Mark Evans, teaches us how it is possible.

A huge shoutout to Robert Winkelmann, for scheduling and making this interview happen! Thank you!

To connect with Mark, visit him on LinkedIn here. 

To learn more about Upvio, visit their website here.

Key takeaways:

1. Part of the story of Upvio aims to solve the question of "why should we be restricted by the locality that we are in" by breaking down barriers for patients to communicate globally with the best medical professionals to receive the best care possible. 

2. Many big healthcare providers in Australia (with large, global teams) use U.S.-facing EHRs, which is the main clientele of Upvio's business. 

3. Upvio is moving towards "Emotional", "Conversational", and "Empathic" AI, which is the ability to do virtual consultations and monitor the facial expressions of the patient/person, the tonality and intonation of the patient's/person's voice, and how they react to a question. All of these features would be summarized into a note that can be saved to their patient record.

What is the current state of the healthcare system in Nigeria and how is the country spurring innovation in Africa? Medical Student at Ambrose Alli University, Abraham Obianke, educates us on what is being done.

To connect with Abraham, find him on LinkedIn here. 

Key Takeaways:

1. Nigeria has a shortage of medical professionals because they are not well-compensated. The lack of compensation compels doctors to move to other areas, which include the United Kingdom and the United States. 

2. In an average medical school class in Nigeria, 70% of graduates will move to other parts of the world where their skills are more valued. 

3. Because of the lack of modern medical equipment and government policies that encourage public health initiatives, Nigeria has expedited the use of technology in its healthcare system.

How can we empower and integrate no-code platforms in AI, APIs, and data sources? Chief Marketing Officer of SmythOS, Michael Walker II, educates us on its possibilities.

To connect with Michael, find him on LinkedIn here.

To learn more about SmythOS, please find more here.

A huge shoutout to Adrienne Uthe of Kronus Communications for scheduling and making this interview happen. Thank you!

To learn more about Kronus, please find more here. 

Key Takeaways:

1. As AI advances, the technology becomes more user-friendly. 

2. SmythOS aims to be the happy medium between GPTs and customized AI solutions. 

3. Oversight regulatory bodies are necessary because AI is here and it is not going anywhere.

Why should healthspan technologies be a priority for investors? Chief Investment Officer of Hevolution Foundation, Dr. William Greene tells us why. 

To connect with Dr. Greene, find him on LinkedIn here.

To learn more about Hevolution Foundation, find their website here.

A huge shoutout to the APCO and Hevolution teams for scheduling and making this happen. Thank you!
 
Key Takeaways:

1.  The solution to solving chronic diseases in aging populations lies in addressing the technological, care, and approach gaps. 

2. About 5% of people globally develop cancer in their lifetime and 100% of people develop chronic, debilitating diseases, which demonstrates that the market for healthspan technologies is vast and underserved. 

3. Thinking holistically from idea, science, and then translation is essential in the cause and treatment of diseases for patients.

What is the story behind the Hevolution Foundation? Chief Executive Officer, Dr. Mehmood Khan, educates us on how the organization is addressing the increasing rates of age-related disabilities and diseases while advancing science.

To connect with Dr. Khan, find him on LinkedIn here.

To learn more about Hevolution Foundation, find their website here,

A huge shoutout to the APCO and Hevolution teams for scheduling and making this happen. Thank you!

Key Takeaways:

1. The Hevolution Foundation was created by a royal order to address the huge, worldwide demographic change, including the significant healthcare and global economic burden. 

2. The mission and vision of the Hevolution Foundation aim to answer how do you democratize the extension of a healthy life span for all.

3. World leaders must look at the fields of aging biology and geroscience in the following three ways:

I. Aging and the demographic changes it has on society should be a high priority for every world leader.
II. How we can better address the field of geroscience.
III. The compression of the time period that people live with disease.

How can we use AI to reduce medical supply costs and decrease order times in the healthcare supply chain? Chief Executive Officer of Grapevine Medical Supply & Procurement, Luká Yancopoulos, educates us on how it is possible.

To connect with Luká , find him on LinkedIn here.

To learn more about Grapevine Medical Supply & Procurement, please find more here.

A huge shoutout to Adrienne Uthe of Kronus Communications for scheduling and making this interview happen. Thank you!

To learn more about Kronus, please find more here. 

Key Takeaways:

1. The origin of Grapevine came from Luka's desire to contribute to a solution that his parents were facing while they were at risk taking care of patients during COVID.

2. Diversifying spend among suppliers and creating a more competitive marketplace decreases costs and saves time. 

3.  1/2 trillion is spent on medical supplies and pharmaceuticals and Grapevine aims to cut that in half in the near term across all medical practices.

How can we usher in non-insurance wellness benefits today? Chief Growth Officer Of Well-Genie, Chris Mathew, tells us how it is possible.

To connect with Chris, find him on LinkedIn here.

To learn more about Well-Genie, please find more here. 

A huge shoutout to our mutual friend Tiffany Ryder for connecting us and making this interview happen. Thank you!

Key Takeaways:

1. Well-Genie is focused on generic medications, wellness tools, and the GLP-1 marketplace.

2. Patient Advocacy and Navigation are essential in helping people move forward in their health journey. 

3. When constructing policy for wellness benefits, the "way it's always been done" should not be the default, and we must look at this from a different perspective and new information.

How can one make a lateral career move from the clinical to the consulting side of healthcare? AI startup advisor and nurse, Dr. Karen B Seagraves, tells us her story of how she did it and how she sees the integration of AI in healthcare.

To connect with Karen, find her on LinkedIn here. 

Key Takeaways:

1. Having clinician, administrator, researcher, and business perspectives is crucial in deciding whether medical products/services by companies will impact the healthcare system. 

2. Making the EHR accessible to nurses is essential in helping patients receive the best possible care. 

3. Access to patient information is needed to help save a patient's life and provide them with a better outcome while ensuring healthier communities.

How can you make EHR integration painless? CEO & Co-Founder of Topology Health, Alex Goel, teaches us how it is possible.

To connect with Alex, find him on LinkedIn here. 

To learn more about Topology Health, please find more here. 

Key Takeaways:

1. Pre-Topology Health, there were not any developer-focused tools for building EHR integration into applications or other health IT systems. 

2. Topology Health creates customized solutions for clients in EHR integration based on the data needs while ensuring a use-case-first perspective. 

3. Provinces can implement their rules and regulations around the data privacy of Canadians.

How will AI and Digital Therapeutics role affect the Indian Healthcare System? Dr. Manthan Mehta teaches us what to expect.

To connect with Dr. Mehta, connect with him here. 

Key Takeaways:

1. Healthcare is not just about curing illnesses, but also about improving the quality of life and where you marry science and empathy. 

2. Disease management must be more proactive, personalized, and accessible to support patients in navigating the healthcare system.

3. Physicians play the biggest role in AI Healthcare because they are the gatekeepers and advocates for AI healthcare. AI is a tool for them and they will use those insights and apply them to patient care.

How can we "create more capacity to care" with research and development on LLMs in patient-facing medical software? Emergency Medicine Physician and VP of Clinical AI of Fabric, Dr. Jon Pangia, tells us how it can be done.

To connect with Dr. Pangia, please find him on LinkedIn here.

To learn more about Fabric, please visit their website here. 

Key Takeaways:
1. Fabric started with the central question of "how we can help healthcare", and then evolved to using digital healthcare as a software service for hospitals to help patients in and through the emergency department with better awareness and follow-up after their visit. 

2. If physicians begin experimenting with AI, then there will be more tools to help them become better at their profession.

3. Policymakers should focus on the bad actors instead of writing regulations that will become obsolete in a short amount of time.

How are the regulatory landscape and market compliance practiced when determining the safety of AI software that would impact healthcare globally? Digital Health Thought Leader, Rudolf Wagner, tells us how.

To connect with Rudolf, connect with him on LinkedIn here. 

Key Takeaways:

1. Germany has a two-fold regulatory environment for software as a medical device. The first is those who produce AI for clinical use, and then what happens in the hospital. 

2. When a major situation occurs, there is a change to a more strict regulation. 

3. Software is measured in a matter of days and not years and the current regulatory environment needs to get ahead of the market or allow people to be on their own.

How do we make sure that areas, such as District 14 of Louisiana do not get left behind in the AI healthcare economy? State Representative, Michael Echols, teaches us what can be done.   

To learn more about Michael, visit his website here.

For more information on Michael's radio show "Echols at 8", visit the KMLB website here. 

Key Takeaways:  

1. Michael has always been involved with the local community, serving on non-profit boards and holding public office ranging from city councilman to state representative.   

2.  Louisiana is currently disjointed in its specialty medical education, but in the next 5-10 years most of the primary care voids will be filled in both the rural and urban markets of the state.  

3. The main AI question that needs to be asked is: How do you protect patients' data with HIPAA while aligning fair incentives where insurance companies cannot just use AI to deny claims and figure out core disease states from those claims? 

* Please note that this interview is informational and is not meant as an endorsement/support/advocacy.

How can we have more constructive conversations around AI healthcare policy? Former Congressman, AI Healthcare Thought Leader, and Vice Chairman of Prime Policy Group, Tom Reed, tells us how.

To connect with Tom, find him on LinkedIn here.

Or, follow Tom on X here.

To learn more about Prime Policy Group, find their page here.

Key Takeaways:

1. Tom's first speech on the House Floor dealt with diabetes and was the Co-Chairman of the House Diabetes Caucus. In conjuction with the technological advancements, diabetes is a personal passion of his because of his family ties and would love to see a cure for the disease. 

2. While cost is an important part of healthcare, the question that we should ask is: How do you measure good quality outcomes?

3. Always know your audience and bring a solution to their problem and understand the motivations of the member. Is it to be re-elected etc...Also,  the issue should apply to their district or state.

How do we advance the citizen and patient voice across health and healthcare while integrating AI into its operations? CEO and Board Advisor For AI and Digital Health Companies, Jon Warner, teaches us how.

To connect with Jon, find him on LinkedIn here. 

Key Takeaways:

1. All technology these days is somewhat AI-driven so it is impossible to ignore. 

2. Reimbursement drives so much innovation and technologists must understand where the money flows and how it creates workflow.

3. There has to be more effort invested in how to create the framework 
to help humanity and not hinder it.

How do we change the stigma of addition and make sure that people get the help that they need? Executive Director of the Matthew Perry Foundation of Canada, Caitlin Morrison, teaches out how. Thank you for sharing Matthew's story with us.

A huge thank you to Kayla Folo for your help in bringing the story of the Matthew Perry Foundation of Canada to the public.

To learn more about the Matthew Perry Foundation of Canada, please visit their website here.

Key Takeaways:

1. There is an addiction crisis and people need support, but there is not enough of it for those who are struggling.

2. AI allows us to understand more about the brain and help us find real treatments beyond just recovery so that the brain can heal itself naturally.

3. Because of the breakthroughs that AI is making in healthcare, the technology can identify genetic markers in individuals in determining those who are at risk of developing an addiction and constructing an individualized treatment plan.


Comment pouvons-nous de l'addiction et aide ceux qui en ont besoin? La directrice exécutive de la Fondation de Matthew Perry de Canada, Caitlin Morrison, elle nous enseigne. Merci beaucoup en partageant l'histoire de ton frère, Matthew Perry, avec nous.

Merci beaucoup á Kayla Folo pour ton soutien en partageant l'histoire de the Matthew Perry Foundation à la publique.

Pour appendre de the Matthew Perry Foundation of Canada, connectez-vous ici.

Les Principales Conclusions:

1. Il y a une crise de l'addiction et les gens ont besoin de soutien, mais il n'y en a pas assez pour ceux qui luttent.

2. L'IA nous permet de mieux comprendre le cerveau et nous aide à trouver de véritables traitements, au-delà de la simple récupération, afin que le cerveau puisse se guérir naturellement. 

3. Au cause aux avancées du IA en la santé publique, la technologie peut identifier des marqueurs genetiques dés personnes en déterminant ceux qui risquent de développer une addiction et en élaborant un plan de traitement individualisé.

How can precision wellness and healthcare be made cheaper, safer, and more efficient in contrast to what is available on the market? Chief Executive Officer of EndoDNA, Len May, teaches us how it is possible. 

To connect with Len, find him on LinkedIn here.
To learn more about EndoDna, visit their website here.
To learn more about Len's coaching services, visit his website here.
To listen to Len's podcast, "Everything is Personal", listen to his podcast here.
To buy Len's book, purchase his book here. 

Key Takeaways: 

1. The origin of EndoDNA started with Len's interest in plant genetics and human genomics and drove him into the precision health and wellness space in healthcare. 

2. The goal of EndoDNA is to use their technology and AI to have a person's genotype to help design an individualized treatment plan that has a feedback loop that illustrates similar individuals that have undergone said individualized treatment plan, which proves it is efficacious. 

3. Preventative measures are essential in reducing the cost of healthcare, such as the use of genetics and epigenetics. With the addition of AI, healthcare professionals will be able to better understand their patients, and insurance companies will reduce the burden on themselves. 

 *Please note that this interview is informational and is not meant as an endorsement/support/advocacy.

How can hematology help us understand the application of AI to the drug discovery process? AI Expert and Scientific Researcher of Hematology at Institut Cochin, Tatayana Tavella teaches us how.

To connect with Tatyana, visit her Linkedin here.
To read more about Tatayna's research, visit her Google Scholar page here.

Key Takeaways:

1. Tatyana's pharmacology internship at the National Institutes of Health is what drove her to do a PhD. 

2. The use of computational tools in the drug discovery process have been used since the 1970s, but its increased use occurred when it matured into machine learning and generative AI in 2018. 

3. The three limitations of AI in the drug discovery process are the quality of the data, transparency (trust), and capability.

*Please note that this interview is informational and is not meant as an endorsement/support/advocacy.

Why is National Colorectal Cancer Awareness Month so important? Senior Vice President, Global Public Affairs at Guardant Health, Jenn Higgins, teaches us why.

To learn more about Guardant Health, visit their website here.
To learn more about Shield Cancer Screen, visit their website here. 

A huge thank you to Melissa Marasco of Guardant Health for scheduling and making this happen. Thank you!

Key takeaways: 

1. Since its inception in 2012, the goal of Guardant Health was to be the organization for the Continuum of Care, which includes people who have never had cancer, survivors, treatment, and monitoring.   

2. With 50 million Americans unscreened for colorectal cancer, Shield Cancer Screen helps improve adherence and alleviates fears of screening.   

3. Maximizing innovation and minimizing the regulatory burden will help companies get their technology products into the hands of patients.

*Please note that this interview is informational and is not meant as an endorsement/support/advocacy.

Healthcare Thought Leader & Visiting Research Fellow at the Paragon Health Institute, Kev Coleman, highlights key considerations to watch for AI healthcare policy under a Trump 2.0 administration.

To read more of Kev's research, please visit here.

Stay tuned for the Paragon consolidated AI page, and Kev's paper with Michael Penina from Duke University that will be announced at a later time.

For further insights, read Kev's paper "Healthcare AI Regulation: Guidelines for Maintaining Public Safety and Innovation", which can be found here. 

This paper examines the main challenges of AI regulation in healthcare and the second part provides guidelines to help policymakers avoid misregulation. 

Key Takeaways: 

1. The key policy areas that must be addressed in AI healthcare policy are public safety and privacy while maintaining world leadership. AI healthcare policy will continue to evolve over the next two years. 

2. AI healthcare places a greater reliance on data and post-market surveillance after approval. Implementing this new way of operating so that it does not restrict innovation and cause unnecessary costs is essential for the FDA to consider. 

3. AI consists of various programming methodologies, each with different vulnerabilities depending on the context. Regulations must address subtypes of AI.

*Please note that this interview is informational and is not meant as an endorsement/support/advocacy.